FOLATE RECEPTOR-ALPHA POSITIVE

Clinical trials for FOLATE RECEPTOR-ALPHA POSITIVE explained in plain language.

Never miss a new study

Get alerted when new FOLATE RECEPTOR-ALPHA POSITIVE trials appear

Sign up with your email to follow new studies for FOLATE RECEPTOR-ALPHA POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Eye drop showdown: protecting vision during ovarian cancer fight

Disease control Recruiting now

This study aims to find the best way to protect patients' eyes from side effects caused by a targeted ovarian cancer drug called mirvetuximab soravtansine. It will enroll 100 women with recurrent ovarian cancer whose tumors have a specific marker. Participants will be randomly as…

Matched conditions: FOLATE RECEPTOR-ALPHA POSITIVE

Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

FOLATE RECEPTOR-ALPHA POSITIVE

Get alerted when new FOLATE RECEPTOR-ALPHA POSITIVE trials appear

Eye drop showdown: protecting vision during ovarian cancer fight